Burlingame, CA, United States of America

James G Taylor

USPTO Granted Patents = 95 

 

 

Average Co-Inventor Count = 4.7

ph-index = 15

Forward Citations = 806(Granted Patents)

Forward Citations (Not Self Cited) = 640(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • San Antonio, TX (US) (1996)
  • Jacksonville, FL (US) (2012)
  • Reddick, FL (US) (2017)
  • San Mateo, CA (US) (2013 - 2019)
  • Evansville, IN (US) (2020)
  • Foster City, CA (US) (2012 - 2023)
  • San Francisco, CA (US) (2013 - 2023)
  • Sterling, VA (US) (2023)
  • Bartlett, IL (US) (2011 - 2024)
  • Burlingame, CA (US) (2013 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
GLP-1R Modulating Compounds
Pyrrolo[1,2-b]Pyridazine Derivatives
Cot Modulators
Peptidylarginine Deiminase Inhibitors
Thiadiazole IRAK4 Inhibitors
Zika Virus Inhibitors
Surgical Tissue Retrieval Instruments
Antiviral Compounds
Multi-Tenancy Databases
Transparent Object Migration
Hepatitis C Virus Inhibitors
Query Optimization
95 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of James G Taylor

Introduction: James G Taylor is a prolific inventor based in Burlingame, California, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 62 patents, Taylor focuses on developing innovative compounds that address critical medical conditions.

Latest Patents: Among Taylor's recent work, he has been granted patents for GLP-1R modulating compounds. These patents describe GLP-1R agonists, along with various compositions, methods, and kits related to these compounds. The applications are particularly focused on treating diseases or conditions mediated by GLP-1R, showcasing Taylor's commitment to addressing pressing health issues through scientific innovation.

Career Highlights: Taylor has had an impactful career with significant roles in renowned companies such as Gilead Sciences, Inc. and Gilead Pharmasset LLC. His work at these organizations has been pivotal in advancing pharmaceutical research and development, particularly in the emerging field of GLP-1R modulation.

Collaborations: Throughout his career, James G Taylor has collaborated with esteemed colleagues, including Jeromy J Cottell and John O Link. These partnerships have further fueled his innovative capabilities, allowing him to share insights and knowledge that enhance their collective research efforts.

Conclusion: James G Taylor exemplifies the spirit of innovation through his extensive work in pharmaceutical inventions. His focus on GLP-1R modulating compounds not only reflects his dedication to scientific advancement but also highlights the importance of collaboration in driving meaningful progress in the medical field. As he continues to push the boundaries of research, Taylor remains a prominent figure in the realm of patents and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…